GEOFFREY HOLLAND: Open Payments
NPI 1528126166 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,579 in 170 payments from 13 companies in 2025. Trend: 2023 $1,774 · 2024 $2,269 · 2025 $2,579
Food & beverage: $2,467Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 43 | $437 |
| E.R. Squibb & Sons, L.L.C. | 19 | $355 |
| Otsuka America Pharmaceutical, Inc. | 24 | $342 |
| Janssen Pharmaceuticals, Inc | 22 | $335 |
| Alkermes, Inc. | 13 | $262 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $250 |
| Vanda Pharmaceuticals Inc. | 13 | $226 |
| Neurocrine BioSciences, Inc. | 6 | $95 |
| Axsome Therapeutics, Inc. | 6 | $92 |
| Lundbeck LLC | 4 | $64 |
Products named: COBENFY, UZEDY, REXULTI, CAPLYTA, ARISTADA, INVEGA SUSTENNA, HETLIOZ, SPRAVATO.
Industry payments across NC — which companies pay providers there.
